SEARCH

SEARCH BY CITATION

References

  • 1
    Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13:9096.MEDLINE
  • 2
    Gugenheim J, Crafa F, Fabiani P, Militerno G, Goubaux B, Saint-Paul MC, Ouzan D, et al. Recurrence of virus B hepatitis after liver transplantation. Gastroenterol Clin Biol 1992; 16:430433.MEDLINE
  • 3
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplant in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:18421847.MEDLINE
  • 4
    Perrillo RP, Mason AL. Hepatitis B and liver transplantation. Problems and promises. N Engl J Med 1993; 329:18851887.MEDLINE
  • 5
    Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, Stevenson WS, et al. Prevention of hepatitis B “rerecurrence” after a second liver transplantation—the role of maintenance of polyclonal HBIG therapy. Transplantation 1994; 58:954956.MEDLINE
  • 6
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24:13271333.MEDLINE
  • 7
    al-Hemsi B, McGory RW, Shepard B, Ishitani MB, Stevenson WC, McCullough CS, Pruett TL. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization. Clin Transplant 1996; 10:668675.MEDLINE
  • 8
    Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997; 64:410414.MEDLINE
  • 9
    Gugenheim J, Baldini E, Ouzan D, Mouiel J. Absence of initial viral replication and long term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc 1997; 29:517518.MEDLINE
  • 10
    Burbach GJ, Bienzle U, Neuhaus R, Hopf U, Metzger WG, Pratscke J, Neuhaus P. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997; 63:478480.MEDLINE
  • 11
    Stephan W. Inactivation of hepatitis viruses and HIV in plasma derivatives by treatment with β-propiolactone/UV irradiation. Curr Stud Hematol Blood Transfus 1989; 56:122127.MEDLINE
  • 12
    Stephan W, Fasold. Intravenöses human-immunoglobulin durch chemische modifizierung mit β-propiolacton. Radiochemische unterschungen. Arzneim-Forsch 1980; 30:20902093.
  • 13
    Tur-Kaspa R, Klein A, Aharonson S. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992; 16:13381342.MEDLINE
  • 14
    Chao Y-C, Lee C-M, Tang H-S, Govindarajan S, Lai MMC. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology 1991; 13:345352.MEDLINE
  • 15
    Safadi R, E'id A, Ilan Y, Ashur Y, Jurim O, Shouval D. Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following transplantation? Transplant Proc 1997; 29:26802683.MEDLINE
  • 16
    Glockner WM. Kinetik von immunglobulin G nach intravenöser oder intramuskulärer applikation. Patient-Infektion-Immunglobulin. Munchen: Springer-Verlag. 1984;3338.
  • 17
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364.MEDLINE
  • 18
    Yoffe B, Burns DK, Bhatt HS, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 1990; 12:187192.MEDLINE
  • 19
    Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, Brechot C. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation 1990; 49:11551158.MEDLINE
  • 20
    Pontisso P, Poon MC, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J Clin Res Ed 1984; 288:15631566.MEDLINE
  • 21
    Davison F, Alexander GJ, Trowbridge R, Fagan EA, Williams R. Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers. A lack of relationship with serum markers of replication. J Hepatol 1987; 4:3744.MEDLINE
  • 22
    Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, et al. Recurrence-free long term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997; 226:356368.MEDLINE
  • 23
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14:104111.MEDLINE
  • 24
    Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Büschenfelde K-H, Neuhaus P, Gerken G. Hepatitis B virus with highly antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27:254263.MEDLINE
  • 25
    Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology 1998; 27:294297.MEDLINE
  • 26
    Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996; 77:18251831.MEDLINE
  • 27
    Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24:489493.MEDLINE
  • 28
    Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27:213222.MEDLINE
  • 29
    Shih JW, Cote PJ, Dapolito GM, Gerin JL. Production of monoclonal antibodies against hepatitis B surface antigen (HBsAg) by somatic cell hybrids. J Virol Methods 1980; 1:257273.MEDLINE
  • 30
    Wands JR, Zurawski VR. High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology 1981; 80:225232.MEDLINE
  • 31
    Fung J, Ostberg L, Shapiro R, Todo S, Demetris A, Starzl T. Human monoclonal antibody against hepatitis B surface antigen in preventing recurrent hepatitis B following liver transplantation [Abstract]. In: HollingerFB, LemonSM, MargolisHS, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1990;651.
  • 32
    Ogata N, Ostberg L, Ehrlich PH, Wong DC, Miller RH, Purcell RH. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci U S A 1993; 90:30143018.MEDLINE
  • 33
    Park SS, Ryu CJ, Gripon P, Guguen-Guillouzo C, Hong HJ. Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus. Hybridoma 1996; 15:435441.MEDLINE
  • 34
    Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, Uhlmann R, Tzahor T, et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology 1998; 93:154161.MEDLINE